James Cheryl
Known title: SVP, CHROCIK: 0001916128
Associated companies
Transaction History
| CVSA | ▼ Sell | Tax Withholding | 811 | $39K | 2/28/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 507 | $22K | 8/24/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 4,660 | $200K | 8/23/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 832 | $33K | 2/28/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 5,350 | $213K | 8/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.